Non-peptide fibrinogen receptor antagonists.: 4.: The synthesis of [3H]L-756,568.

被引:0
|
作者
Hamill, TG
Hutchinson, JH
Brashear, KM
Hartman, GD
机构
[1] Merck Res Labs, Dept Pharmacol, W Point, PA 19486 USA
[2] Merck Res Labs, Dept Med Chem, W Point, PA 19486 USA
来源
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 1999年 / 42卷 / 06期
关键词
fibrinogen receptor antagonist; L-756,568; catalytic tritiation;
D O I
10.1002/(SICI)1099-1344(199906)42:6<605::AID-JLCR222>3.0.CO;2-L
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The synthesis of [H-3]L-756,568, an orally active fibrinogen receptor antagonist, is described. Two synthetic pathways were developed using either bromoindoles 2a/2b or bromoaryl sulfonamide 11 as the precursor. Use of the bromoaryl sulfonamide precursor led to [H-3]L-756,568 with higher radiochemical purity, higher radiochemical yield, and slightly higher specific activity.
引用
收藏
页码:605 / 609
页数:5
相关论文
共 50 条
  • [21] Beta-amino acid derivatives as orally active non-peptide fibrinogen receptor antagonists
    Kottirsch, G
    Zerwes, HG
    Cook, NS
    Tapparelli, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (06) : 727 - 732
  • [22] Non-peptide αvβ3 antagonists.: Part 4:: Potent and orally bioavailable chain-shortened RGD mimetics
    Coleman, PJ
    Askew, BC
    Hutchinson, JH
    Whitman, DB
    Perkins, JJ
    Hartman, GD
    Rodan, GA
    Leu, CT
    Prueksaritanont, T
    Fernandez-Metzler, C
    Merkle, KM
    Lynch, R
    Lynch, JJ
    Rodan, SB
    Duggan, ME
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (17) : 2463 - 2465
  • [23] Rigid, centrally constrained non-peptide GPIIbIIIa antagonists. The synthesis and biological activity of 6-chloro-benzodiazepinediones.
    Robarge, KD
    Olivero, AG
    Blackburn, BK
    Lee, A
    Matamoros, R
    Bunting, S
    Refino, K
    Pater, C
    Bullens, S
    Wu, D
    Lipari, T
    DeGuzman, L
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 130 - MEDI
  • [24] Different domains in the CCK-B/gastrin receptor confer high affinity for peptoid vs non-peptide antagonists.
    Schmitz, F
    Wu, MJ
    Beinborn, M
    Kopin, AS
    GASTROENTEROLOGY, 1996, 110 (04) : A1116 - A1116
  • [25] Structure-activity relationship of 2-amino-3-heteroaryl-quinoxalines as potent, non-peptide interleukine-8-receptor antagonists.
    Li, JJ
    Yue, WS
    Trivedi, BK
    Miller, SR
    Connor, DT
    Roth, BD
    Low, JE
    Hellig, DJ
    Yang, WX
    Qin, SX
    Hunt, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U562 - U562
  • [26] Synthesis and sar of benzoifuran-based H3 receptor antagonists.
    Sun, MH
    Zhao, C
    Curtis, M
    Faghih, R
    Gfesser, G
    Miller, TR
    Marsh, K
    Wetter, D
    Esbenshade, TA
    Hancock, AA
    Cowart, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U918 - U918
  • [27] Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide
    Sugihara, H
    Fukushi, H
    Miyawaki, T
    Imai, Y
    Terashita, Z
    Kawamura, M
    Fujisawa, Y
    Kita, S
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (04) : 489 - 502
  • [28] Molecular interactions of cyclam and bicyclam non-peptide antagonists with the CXCR4 chemokine receptor
    Gerlach, LO
    Skerlj, RT
    Bridger, GJ
    Schwartz, TW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (17) : 14153 - 14160
  • [29] Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [3H]BIBN4096BS
    Schindler, M
    Doods, HN
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 442 (03) : 187 - 193
  • [30] Investigation of the 4-O-alkylamine substituent of non-peptide quinolone GnRH receptor antagonists
    DeVita, RJ
    Goulet, MT
    Wyvratt, MJ
    Fisher, MH
    Lo, JL
    Yang, YT
    Cheng, K
    Smith, RG
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) : 2621 - 2624